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Author Response
We thank Gentzel for his careful 
reading of our article.1 His letter 
to the editor2 is enriching, as it 
facilitates the international debate 
regarding pain treatment and pain 
mechanisms in osteoarthritis (OA). 
Below we respond to each of the 
issues raised. 
As correctly indicated by Gentzel, 
the aim of our article was to 
emphasize the role of the hyper-
excitability of the central nervous 
system (or central sensitization 
[CS]) on pain in patients with OA 
rather than updating the readers 
with our current understanding of 
OA etiology and joint pathophysi-
ology. Considering both peripheral 
and central aspects for a compre-
hensive approach to OA pain 
does not imply “ignorance” of the 
chronic infl ammatory condition, as 
suggested by Genztel. As the sci-
entifi c community is well informed 
about the pathological changes in 
joint structures in patients with 
OA, the central pain mechanisms 
require more attention. Our article 
reviewed and evaluated the exist-
ing scientifi c evidence addressing 
CS in OA pain in order to establish 
whether there were enough argu-
ments to support the role of CS in 
chronic pain related to OA. To cite 
our own article, “[i]n addition to the 
pathological changes in articular 
structures, changes in central pain 
processing or central sensitization 
appear to be involved in osteo-
arthritis pain.”1(p842)
We do not doubt the role that tis-
sue modifi cation and destruction, 
typically observed in patients 
with OA, can have in explaining 
pain during the early stages of the 
disease. However, it is now well 
recognized that the central nervous 
system becomes hyperexcitable 
as pain is prolonged in time. This 
hyperexcitability often implies that 
patients’ symptoms become less 
associated with what is happening 
in the peripheral tissues, includ-
ing the joints, which may explain 
the common observation of dis-
crepancies between radiological 
changes identifi ed in patients with 
OA and the degree of pain and 
disability3,4 and the fact that some 
patients with OA show symptoms 
even after prosthetic substitution.5 
Nevertheless, even in a person 
with chronic pain, peripheral no-
ciceptive input from the damaged 
joint can modulate CS, as has been 
shown by modulation of central 
hyperexcitability in patients with 
OA in the form of amelioration of 
widespread analgesia6–8 and res-
toration of altered spinal refl exes9 
after implementation of different 
treatment modalities, mainly ad-
dressing the affected joints (eg, by 
joint replacements). Thus, tissues 
can be important even in cases of 
chronic, localized OA pain. 
Central sensitization is not present 
in all patients with chronic OA pain. 
Moreover, we acknowledge that 
CS is unlikely to be the etiological 
mechanism in a subgroup of the 
OA population (chronic infl amma-
tion is not etiologic to OA either), 
but there is increasing evidence 
suggesting that the presence of CS 
in this OA subgroup is of clinical 
importance.10–12 Probably the main 
goal of our article was to alert clini-
cians about this subgroup where 
CS can be the most dominant pain 
mechanism (ie, pain experience 
disproportionate to the nature and 
extent of injury, widespread pain 
distribution, generalized allodynia, 
and hyperalgesia). In those cases, 
we suggest a broader manage-
ment approach, focusing treatment 
more on diminishing the hyper-
sensitivity of the central nervous 
system than on addressing the joint 
dysfunctions.  
We recognize that clinically catego-
rizing patients with OA as having 
CS can be challenging, as no gold 
standard method of assessment ex-
ists. In fact, pain hypersensitivity 
in OA has been identifi ed mostly 
within laboratory settings using 
equipment that is costly and not 
readily available to clinicians (ie, 
psychophysical testing with vari-
ous stimuli,13 brain imaging stud-
ies14). That is why we propose to 
use a mechanism-based model 
mostly based on recognition of 
signs and symptoms for diagnosing 
CS,15 following recommendations 
of renowned authors in the fi eld 
of pain.16 We do not think these 
models are “open to too much con-
jecture” or can lead to “entrench-
ing of informational cascades,” as 
Gentzel suggests, although more 
evidence-based and validated clini-
cal strategies are needed to more 
readily and systematically identify 
CS in patients with OA pain. Classi-
fi cation of pain in terms of mecha-
nism should constitute a priority, 
considering that interventions at 
the peripheral tissue level (eg, sur-
gery) are less successful when CS 
is suspected.4
The biomedical model falls short 
in explaining chronic musculoskel-
etal pain.17 Despite the fact that 
“[s]cience is busy identifying the 
causes of many chronic disease 
conditions such as OA,” unfortu-
nately physical therapists continue 
dealing every day with people 
with chronic pain due to OA. So, 
in the same way Gentzel refl ected 
on the relevant question of at what 
point of tissue degradation does 
OA become incurable, we suggest 
an alternative question: At what 
point in time does the transition 
from acute to chronic OA pain 
occur? In other words: when CS 
develops in patients with OA pain, 
will it still be possible to reverse 
the situation, or will this be less 
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likely? There is evidence showing 
sensitization occurring in people 
with subacute musculoskeletal 
pain18 and evidence pointing to the 
ability of CS to modulate the transi-
tion from acute to chronic pain.18,19 
In addition, CS has been shown to 
mediate the effects of interventions 
applied to peripheral tissues.4   
As has been pointed out by Dieppe 
and Lohmander,19 OA joint dam-
age may be associated with clinical 
problems, but the severity of joint 
disease is only weakly related to 
that of the clinical problem. They 
stated that clinicians dealing with 
OA are faced with a complex inter-
action between local events in the 
joint, pain sensitization, the cortical 
experience of pain, context (ie, 
psychosocial, economic, and other 
factors), and what people are doing 
in their everyday lives.19 Therefore, 
we should move on our thinking 
and broaden our view from only 
addressing joint dysfunctions to a 
more comprehensive approach ad-
dressing the brain, the central pain 
mechanisms, and the biopsycho-
social model applied to chronic OA 
pain.17  
We think Gentzel’s criticism of our 
use of the term “might” or “may” 
throughout the text is not justifi ed 
because our article was intended 
to be a proposal for chronic pain 
management in patients with OA, 
and not a statement of fact. He 
also alerts us that animal models 
of musculoskeletal pain do not 
closely mirror the human condi-
tion.20 Indeed, we know pain is a 
complex, multidimensional, per-
sonal, and subjective experience 
that only humans can express.21 
However, curiously, little attention 
to psychosocial aspects of human 
OA pain was detected in Gentzel’s 
reasoning, as addressing “basic 
malfunctions of normal physiol-
ogy” was stated to be one his main 
end purposes.     
In conclusion, it is key for physi-
cal therapists to acknowledge that 
an important subgroup of patients 
with OA develop hyperexcitability 
of the central nervous system and 
that CS plays a crucial role in the 
pain reported by these patients. 
Recent studies published in well-
respected journals support our 
arguments.22–25
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In Appendix 3 of this article published in the July 2013 issue of PTJ, the testing protocol for the Sharp-
ened Romberg test with eyes open is described incorrectly. The correct description is:
(3) Sharpened Romberg test–eyes open: Each participant should stand on a level surface wearing fl at 
shoes with his or her feet aligned in a strict tandem heel-to-toe position, arms crossed over the chest, 
and the open palm of the hand falling on the opposite shoulder. Once stable, the participant should 
attempt to maintain that position for 30 seconds. If the participant fails to maintain the position by 
movement of either arms or feet, the time taken to failure should be noted.
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